The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

 Automating the Future of Fill/Finish

Topic

Kai Lipinski, PhD, is the chief scientific officer of Vibalogics.

Articles

Although new single-use technologies offer the flexibility needed to overcome several challenges in ATMP production, there are many considerations and hurdles manufacturers must be aware of when scaling. 

Scaling Manufacturing Processes Using  Single-Use Technologies

Webcasts

Webinar Date/Time: Tue, Feb 28, 2023 2:00 PM EST

Nanoparticle Platform Technologies for Efficient Oral and Parenteral Drug Delivery

Webinar Date/Time: Thu, Feb 23, 2023 11:00 AM EST

Multiparticulate Approaches to the Design, Development, and Commercialization of Flexible Dosage Forms

Webinar Date/Time: Tuesday, February 28th, 2023 at 11am EST | 8am PST | 4pm GMT | 5pm CET


Meeting the Container Closure Integrity Requirements in the Revised EU Annex 1: A Science-Based Holistic Approach

The COVID-19 pandemic has led to many changes and shifts in the pharmaceutical industry, specifically with how pharmaceutical companies develop vaccines.

Recipharm: Combatting Future Viral Threats with Vaccine Advances

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

The change would impact every package and hundreds of systems. 

FDA Proposes Longer National Drug Code 

CBM’s plasmid manufacturing offering is designed to provide phase-appropriate plasmids on demand for companies working on cell and gene therapies.

The Center for Breakthrough Medicines Announces Plasmid Manufacturing Service

The new plasmid manufacturing facility aims to increase BioNTech’s autonomy and flexibility in manufacturing. 

BioNTech Strengthens Manufacturing Capabilities with First In-house Plasmid DNA Manufacturing Facility

Improvements to Fluid Air’s Magnaflo filter blowback system are intended to increase powder yield in PolarDry Models 001 and 004.

Fluid Air Launches Enhanced Magnaflo Filter Blowback System

Webinar Date/Time: Thursday February 24, 2023 at 11am EST | 10am CST | 8am PST
